From the clinical perspective, our study strongly suggests that the rs4374383/rs6726639 SNPs of MERTK may represent a useful genetic biomarker to identify those patients with chronic liver diseases who are at high risk of progression and therefore deserve a more rigorous follow-up for HCC surveillance. The gene discussed is MERTK; the disease is hepatocellular carcinoma.